Arkadios Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-75
Closed -$30K 810
2021
Q3
$30K Sell
75
-122
-62% -$50.7K ﹤0.01% 1066
2021
Q2
$72K Buy
197
+9
+5% +$3K 0.01% 812
2021
Q1
$54K Sell
188
-4
-2% -$1.11K 0.01% 670
2020
Q4
$47K Buy
192
+56
+41% +$13.3K 0.01% 568
2020
Q3
$32.7K Sell
136
-5
-4% -$1.04K 0.02% 490
2020
Q2
$26.4K Sell
141
-28
-17% -$4.47K 0.01% 487
2020
Q1
$21.3K Sell
169
-29
-15% -$4.35K 0.01% 476
2019
Q4
$34.1K Buy
+198
New +$27.4K 0.02% 370

Other funds holding CRL